Search clinical trials for: Ibandronic acid

Total 23762 results

Clinic of Endocrinology and Metabolic Disorders...
Clinic for Orthopedic Surgery, Skopje; General Hospital, Kumanovo; General Hospital... and other collaborators

Completed

Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis

Osteoporosis
University of Turku
Hoffmann-La Roche

Unknown

Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

Breast Cancer

Finland
Azienda Ospedaliero-Universitaria Careggi

Completed

Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors (BONADIUV)

Breast Cancer

Italy
Dr. Ashish Kumar

Completed

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

Cirrhosis

India
Chugai Pharmaceutical

Completed

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

Primary Osteoporosis

Japan
Shinshu University

Recruiting

Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Osteoporosis

Japan
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Italy, Chile, Russian Federation, Hungary, United Kingdom, Poland, Guatemala, Germany, Mexico, Puerto Rico, Greece, Australia, Switzerland, Argentina, Panama
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Mexico, Germany, Russian Federation, Italy, Hungary, Belgium, Chile, France, Argentina, Australia, Switzerland, Guatemala, Puerto Rico, Poland, Panama, United Kingdom, Canada
Organon and Co

Completed

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Postmenopausal Osteoporosis
GlaxoSmithKline

Completed

BONVIVA(Ibandronate) PMS(Post-marketing Surveillance ) (BONPMS)

Osteoporosis

Korea, Republic of
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Completed

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Breast Cancer
Wales Cancer Trials Unit
Velindre NHS Trust

Unknown

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Breast Cancer | Metastatic Cancer | Hypercalcemia of Malignancy

United Kingdom
Hoffmann-La Roche
GlaxoSmithKline

Completed

The Effect Of Oral Ibandronate In Male Osteoporosis (STRONG)

Male Osteoporosis

United States
Hoffmann-La Roche
Roche Pharma AG

Terminated

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (COMPARE)

Multiple Myeloma

Germany
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Pain; Bone Neoplasms; Neoplasm Metastasis

Bulgaria
Hoffmann-La Roche

Completed

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Belgium, Luxembourg, Austria, Greece, Ireland
Hoffmann-La Roche

Completed

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Postmenopausal Osteoporosis

Poland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Post-Menopausal Osteoporosis

United States, Germany, United Kingdom, Spain, Italy, Hungary, Belgium, Mexico, Poland, Denmark, France, Norway, Brazil, Czechia
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
Hoffmann-La Roche

Completed

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
Hoffmann-La Roche
GlaxoSmithKline

Completed

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.

Post Menopausal Osteoporosis

France
Hoffmann-La Roche

Withdrawn

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Pain | Neoplasm Metastasis | Bone Neoplasm

Greece
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Pain; Bone Neoplasms; Neoplasm Metastasis

Bulgaria
GlaxoSmithKline

Completed

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

Osteoporosis

United States
Hoffmann-La Roche

Completed

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

Pain; Bone Neoplasms; Neoplasm Metastasis

Turkey
Hoffmann-La Roche

Completed

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Post Menopausal Osteoporosis

Philippines, Taiwan, Thailand, Hong Kong, Indonesia
Hoffmann-La Roche

No longer available

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Postmenopausal Osteoporosis

Taiwan
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

Post-Menopausal Osteopenia

France
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Post Menopausal Osteoporosis

United States, Puerto Rico
Germans Trias i Pujol Hospital

Withdrawn

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

HIV Infections

Spain
GlaxoSmithKline

Completed

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

Osteoporosis

Netherlands
Brigitte Jolles, MD

Terminated

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis

Hip Necrosis | Aseptic Hip Necrosis

Switzerland
Hoffmann-La Roche

Completed

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

Osteoporosis

United States
Hoffmann-La Roche

Completed

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
Hoffmann-La Roche

Completed

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Post-Menopausal Osteoporosis

Turkey, Albania, Bosnia and Herzegovina, Croatia, Macedonia, The Former Yugoslav Republic of, Serbia
Hoffmann-La Roche

Completed

A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Pain; Bone Neoplasms; Neoplasm Metastasis

France
Hoffmann-La Roche

Completed

A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Bosnia and Herzegovina
Cancer Research UK

Completed

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

Pain | Prostate Cancer | Metastatic Cancer

United Kingdom
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Post-Menopausal Osteopenia

United States
GlaxoSmithKline

Completed

BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance) (BONINJPMS)

Osteoporosis

Korea, Republic of
Amgen

Completed

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

Postmenopausal Osteoporosis
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition

Healthy

India
Smerud Medical Research International AS
Oslo University Hospital

Unknown

Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.

Renal Transplant

Norway
M.D. Anderson Cancer Center
Roche Pharma AG

Completed

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Hematological Malignancies

United States
Hoffmann-La Roche

Completed

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Germany
Chinese Society of Lung Cancer

Terminated

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

Lung Cancer

China
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Post-Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, Italy, Belgium, United States, Poland, Denmark, Hungary, Czech Republic, France, Norway, United Kingdom, Australia
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Pain | Breast Cancer | Metastatic Cancer | Hypercalcemia of Malignancy
GlaxoSmithKline

Completed

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

United States

3

Subscribe